Your session is about to expire
← Back to Search
Behavioural Intervention
Virtual Reality for Pediatric ENT Procedures
N/A
Recruiting
Led By Anthony Tolisano, MD
Research Sponsored by Walter Reed National Military Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Pediatric patients, ages 7-17 years old, undergoing an in-office microscope ear examination with possible debridement/instrumentation by a single fellowship trained neurotologist .
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
"This trial will test if Virtual Reality can help children feel less pain and anxiety during ear surgeries in the ENT clinic."
Who is the study for?
This trial is for children who need ear, nose, and throat (ENT) procedures. It's designed to see if Virtual Reality can help reduce their pain and anxiety during these procedures.
What is being tested?
The study tests the use of Virtual Reality as a way to distract kids from pain and calm their nerves in pediatric ENT clinics while they undergo certain medical procedures.
What are the potential side effects?
Virtual Reality is generally safe but may cause dizziness, nausea, or eye strain in some children.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Virtual Reality ArmActive Control1 Intervention
Pediatric patient receiving Virtual Reality during the otologic procedure.
Group II: Standard of Care ArmActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Walter Reed National Military Medical CenterLead Sponsor
140 Previous Clinical Trials
33,073 Total Patients Enrolled
Anthony Tolisano, MDPrincipal InvestigatorWRNMMC
Share this study with friends
Copy Link
Messenger